These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 26266945)

  • 1. A Hamster Model of Diet-Induced Obesity for Preclinical Evaluation of Anti-Obesity, Anti-Diabetic and Lipid Modulating Agents.
    Dalbøge LS; Pedersen PJ; Hansen G; Fabricius K; Hansen HB; Jelsing J; Vrang N
    PLoS One; 2015; 10(8):e0135634. PubMed ID: 26266945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-obesity effects of KR-66195, a synthetic DPP-IV inhibitor, in diet-induced obese mice and obese-diabetic ob/ob mice.
    Lee EY; Kim YW; Oh H; Choi CS; Ahn JH; Lee BW; Kang ES; Cha BS; Lee HC
    Metabolism; 2014 Jun; 63(6):793-9. PubMed ID: 24684824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of liraglutide and sibutramine on food intake, palatability, body weight and glucose tolerance in the gubra DIO-rats.
    Hansen G; Jelsing J; Vrang N
    Acta Pharmacol Sin; 2012 Feb; 33(2):194-200. PubMed ID: 22301859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The DPP-IV inhibitor linagliptin and GLP-1 induce synergistic effects on body weight loss and appetite suppression in the diet-induced obese rat.
    Hansen HH; Hansen G; Paulsen S; Vrang N; Mark M; Jelsing J; Klein T
    Eur J Pharmacol; 2014 Oct; 741():254-63. PubMed ID: 25160746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ezetimibe, a potent cholesterol absorption inhibitor, normalizes combined dyslipidemia in obese hyperinsulinemic hamsters.
    van Heek M; Austin TM; Farley C; Cook JA; Tetzloff GG; Davis HR
    Diabetes; 2001 Jun; 50(6):1330-5. PubMed ID: 11375333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ezetimibe ameliorates intestinal chylomicron overproduction and improves glucose tolerance in a diet-induced hamster model of insulin resistance.
    Naples M; Baker C; Lino M; Iqbal J; Hussain MM; Adeli K
    Am J Physiol Gastrointest Liver Physiol; 2012 May; 302(9):G1043-52. PubMed ID: 22345552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of combined linagliptin and Y2R agonist treatment in diet-induced obese mice.
    Hansen HH; Grønlund RV; Baader-Pagler T; Haebel P; Tammen H; Larsen LK; Jelsing J; Vrang N; Klein T
    Sci Rep; 2021 Apr; 11(1):8060. PubMed ID: 33850212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of shanzha, a Chinese herbal product, on obesity and dyslipidemia in hamsters receiving high-fat diet.
    Kuo DH; Yeh CH; Shieh PC; Cheng KC; Chen FA; Cheng JT
    J Ethnopharmacol; 2009 Jul; 124(3):544-50. PubMed ID: 19454308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CNX-012-570, a direct AMPK activator provides strong glycemic and lipid control along with significant reduction in body weight; studies from both diet-induced obese mice and db/db mice models.
    Anil TM; Harish C; Lakshmi MN; Harsha K; Onkaramurthy M; Sathish Kumar V; Shree N; Geetha V; Balamurali GV; Gopala AS; Madhusudhan Reddy B; Govind MK; Anup MO; Moolemath Y; Venkataranganna MV; Jagannath MR; Somesh BP
    Cardiovasc Diabetol; 2014 Jan; 13():27. PubMed ID: 24460834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. JTT-130, a novel intestine-specific inhibitor of microsomal triglyceride transfer protein, suppresses high fat diet-induced obesity and glucose intolerance in Sprague-Dawley rats.
    Hata T; Mera Y; Tadaki H; Kuroki Y; Kawai T; Ohta T; Kakutani M
    Diabetes Obes Metab; 2011 May; 13(5):446-54. PubMed ID: 21255216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severe hypertriglyceridemia and hypercholesterolemia accelerating renal injury: a novel model of type 1 diabetic hamsters induced by short-term high-fat / high-cholesterol diet and low-dose streptozotocin.
    He L; Hao L; Fu X; Huang M; Li R
    BMC Nephrol; 2015 Apr; 16():51. PubMed ID: 25884847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amylin improves the effect of leptin on insulin sensitivity in leptin-resistant diet-induced obese mice.
    Kusakabe T; Ebihara K; Sakai T; Miyamoto L; Aotani D; Yamamoto Y; Yamamoto-Kataoka S; Aizawa-Abe M; Fujikura J; Hosoda K; Nakao K
    Am J Physiol Endocrinol Metab; 2012 Apr; 302(8):E924-31. PubMed ID: 22275759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The high-fat high-fructose hamster as an animal model for niacin's biological activities in humans.
    Connolly BA; O'Connell DP; Lamon-Fava S; LeBlanc DF; Kuang YL; Schaefer EJ; Coppage AL; Benedict CR; Kiritsy CP; Bachovchin WW
    Metabolism; 2013 Dec; 62(12):1840-9. PubMed ID: 24035454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liraglutide shows superior cardiometabolic benefits than lorcaserin in a novel free choice diet-induced obese rat model.
    Briand F; Brousseau E; Maupoint J; Dubroca C; Costard C; Breyner N; Burcelin R; Sulpice T
    Eur J Pharmacol; 2020 Sep; 882():173316. PubMed ID: 32621913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic metabolic benefits of an exenatide analogue and cholecystokinin in diet-induced obese and leptin-deficient rodents.
    Trevaskis JL; Sun C; Athanacio J; D'Souza L; Samant M; Tatarkiewicz K; Griffin PS; Wittmer C; Wang Y; Teng CH; Forood B; Parkes DG; Roth JD
    Diabetes Obes Metab; 2015 Jan; 17(1):61-73. PubMed ID: 25204356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of anti-obesity and lipid-lowering properties of Vaccinium myrtillus leaves powder extract in a hamster model.
    Zagayko AL; Kolisnyk TY; Chumak OI; Ruban OA; Koshovyi OM
    J Basic Clin Physiol Pharmacol; 2018 Nov; 29(6):697-703. PubMed ID: 30052516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term characterization of the diet-induced obese and diet-resistant rat model: a polygenetic rat model mimicking the human obesity syndrome.
    Madsen AN; Hansen G; Paulsen SJ; Lykkegaard K; Tang-Christensen M; Hansen HS; Levin BE; Larsen PJ; Knudsen LB; Fosgerau K; Vrang N
    J Endocrinol; 2010 Sep; 206(3):287-96. PubMed ID: 20508079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-obesity, anti-diabetic, and lipid lowering effects of the thyroid receptor beta subtype selective agonist KB-141.
    Bryzgalova G; Effendic S; Khan A; Rehnmark S; Barbounis P; Boulet J; Dong G; Singh R; Shapses S; Malm J; Webb P; Baxter JD; Grover GJ
    J Steroid Biochem Mol Biol; 2008 Sep; 111(3-5):262-7. PubMed ID: 18621127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Triphala and its constituents ameliorate visceral adiposity from a high-fat diet in mice with diet-induced obesity.
    Gurjar S; Pal A; Kapur S
    Altern Ther Health Med; 2012; 18(6):38-45. PubMed ID: 23251942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beneficial long-term antidiabetic actions of N- and C-terminally modified analogues of apelin-13 in diet-induced obese diabetic mice.
    Parthsarathy V; Hogg C; Flatt PR; O'Harte FPM
    Diabetes Obes Metab; 2018 Feb; 20(2):319-327. PubMed ID: 28730728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.